Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
School of Population & Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
J Med Internet Res. 2021 Apr 27;23(4):e24861. doi: 10.2196/24861.
Outdoor risky play, such as climbing, racing, and independent exploration, is an important part of childhood and is associated with various positive physical, mental, and developmental outcomes for children. Parental attitudes and fears, particularly mothers', are a major deterrent to children's opportunities for outdoor risky play.
The aim of this study was to evaluate the efficacy of 2 versions of an intervention to reframe mothers' perceptions of risk and change parenting behaviors: a web-based intervention or an in-person workshop, compared with the control condition.
The Go Play Outside! randomized controlled trial was conducted in Canada from 2017 to 2018. Participants were recruited through social media, snowball sampling, and community notices. Mothers of children aged 6-12 years were self-assessed through eligibility questions, and those eligible and consented to participate in the study were randomized into a fully automated web-based intervention, the in-person workshop, or the control condition. The intervention was underpinned by social cognitive theory, incorporating behavior change techniques. Participants progressed through a series of self-reflection exercises and developed a goal for change. Control participants received the Position Statement on Active Outdoor Play. The primary outcome was increase in tolerance of risky play and the secondary outcome was goal attainment. Data were collected online via REDCap at baseline, 1 week, and 3 months after the intervention. Randomization was conducted using sealed envelope. Allocations were concealed to researchers at assignment and data analysis. We conducted mediation analyses to examine whether the intervention influenced elements of social cognitive theory, as hypothesized.
A total of 451 mothers were randomized and completed baseline sociodemographic assessments: 150 in the web-based intervention, 153 in the in-person workshop, and 148 in the control condition. Among these, a total of 351 mothers completed the intervention. At 1 week after the intervention, 113, 85, and 135 mothers completed assessments for each condition, respectively, and at 3 months after the intervention, 105, 84, and 123 completed the assessments, respectively. Compared with mothers in the control condition, mothers in the web-based intervention had significantly higher tolerance of risky play at 1 week (P=.004) and 3 months after the intervention (P=.007); and mothers in the in-person workshop had significantly higher tolerance of risky play at 1 week after the intervention (P=.02). No other significant outcomes were found. None of the potential mediators were found to significantly mediate the outcomes.
The trial demonstrates that the web-based intervention was effective in increasing mothers' tolerance for risk in play.
ClinicalTrials.gov NCT03374683; https://clinicaltrials.gov/ct2/show/NCT03374683.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1186/s13063-018-2552-4.
户外冒险游戏,如攀爬、赛跑和自主探索,是童年的重要组成部分,与儿童的各种积极的身体、心理和发展结果有关。父母的态度和恐惧,特别是母亲的态度和恐惧,是阻碍儿童户外冒险游戏机会的主要因素。
本研究旨在评估两种干预措施改变母亲对风险的看法和改变育儿行为的效果:一种是基于网络的干预,另一种是面对面的研讨会,与对照组相比。
2017 年至 2018 年在加拿大进行了 Go Play Outside!随机对照试验。参与者通过社交媒体、雪球抽样和社区通知招募。通过资格问题自我评估,符合条件并同意参加研究的母亲被随机分配到完全自动化的基于网络的干预、面对面研讨会或对照组。该干预措施以社会认知理论为基础,结合行为改变技术。参与者通过一系列自我反思练习,并为改变制定目标。对照组参与者收到了《积极户外活动立场声明》。主要结果是增加对冒险游戏的容忍度,次要结果是实现目标。数据通过 REDCap 在干预前、干预后 1 周和 3 个月在线收集。采用密封信封进行随机分组。研究人员在分配和数据分析时对分配进行了隐藏。我们进行了中介分析,以检验干预是否如假设的那样影响社会认知理论的各个要素。
共有 451 名母亲被随机分配并完成了基线社会人口统计学评估:150 名在基于网络的干预组,153 名在面对面研讨会组,148 名在对照组。其中,共有 351 名母亲完成了干预。在干预后 1 周,分别有 113、85 和 135 名母亲完成了每个组的评估,在干预后 3 个月,分别有 105、84 和 123 名母亲完成了评估。与对照组的母亲相比,基于网络的干预组在干预后 1 周(P=0.004)和 3 个月(P=0.007)时对冒险游戏的容忍度显著提高;面对面研讨会组在干预后 1 周时对冒险游戏的容忍度显著提高(P=0.02)。未发现其他显著结果。没有发现任何潜在的中介因素对结果有显著影响。
该试验表明,基于网络的干预措施能够有效提高母亲对游戏中风险的容忍度。
ClinicalTrials.gov NCT03374683;https://clinicaltrials.gov/ct2/show/NCT03374683。
国际注册报告标识符(IRRID):RR2-10.1186/s13063-018-2552-4。